• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿科肿瘤学家招募青少年和年轻成年人参与跨网络全国临床试验网络支持性护理癌症临床试验的障碍。

Barriers to Pediatric Oncologist Enrollment of Adolescents and Young Adults on a Cross-Network National Clinical Trials Network Supportive Care Cancer Clinical Trial.

机构信息

Department of Pediatrics, Rush University Children's Hospital, Chicago, Illinois, USA.

Department of Pediatrics, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.

出版信息

J Adolesc Young Adult Oncol. 2022 Feb;11(1):117-121. doi: 10.1089/jayao.2021.0041. Epub 2021 May 13.

DOI:10.1089/jayao.2021.0041
PMID:33983848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8864435/
Abstract

Few studies have explored interventions to improve adolescent and young adult (AYA) cancer care delivery. While many AYAs receive cancer care at NCI Community Oncology Research Program (NCORP) sites, few enroll on clinical trials. Barriers and facilitators to pediatric oncologist activation of and enrollment on an AYA cross-network National Clinical Trials Network (NCTN) supportive care trial were assessed using a survey that was administered to 162 stakeholders representing all 47 children's oncology group (COG) institutions affiliated to an NCORP. Fifty-eight stakeholders participated representing 62% of all sites surveyed. Approximately half of participants (45%) were unaware of the trial. Seven sites had the study open and one enrolled a patient. Reasons for not opening and enrolling on the trial included limited research staff and resources, low anticipated accrual, and lower prioritization of the trial. Enrollment facilitators included having a local "AYA champion," improving communication between pediatric and medical oncology, and having site education on available AYA trials. Interventions focused on increasing site and provider awareness of AYA trials and decreasing local barriers to AYA enrollment are needed.

摘要

很少有研究探索改善青少年和年轻成人(AYA)癌症护理服务的干预措施。虽然许多 AYA 在 NCI 社区肿瘤学研究计划(NCORP)站点接受癌症护理,但很少有参加临床试验的。使用一项调查评估了儿科肿瘤学家激活和参加 AYA 跨网络国家临床试验网络(NCTN)支持性护理试验的障碍和促进因素,该调查分发给代表所有隶属于 NCORP 的 47 个儿童肿瘤学组(COG)机构的 162 名利益相关者。58 名利益相关者参加了调查,占所有调查站点的 62%。大约一半的参与者(45%)不知道这项试验。有 7 个站点开放了该研究,有 1 个站点招募了患者。未开放和招募参加试验的原因包括研究人员和资源有限、预计入组人数低以及对试验的优先级较低。招募的促进因素包括有当地的“AYA 拥护者”、改善儿科肿瘤学和肿瘤学之间的沟通,以及对可用的 AYA 试验进行站点教育。需要针对增加 AYA 试验的站点和提供者的认识,并减少 AYA 入组的地方障碍的干预措施。

相似文献

1
Barriers to Pediatric Oncologist Enrollment of Adolescents and Young Adults on a Cross-Network National Clinical Trials Network Supportive Care Cancer Clinical Trial.儿科肿瘤学家招募青少年和年轻成年人参与跨网络全国临床试验网络支持性护理癌症临床试验的障碍。
J Adolesc Young Adult Oncol. 2022 Feb;11(1):117-121. doi: 10.1089/jayao.2021.0041. Epub 2021 May 13.
2
Barriers and Facilitators to Adolescent and Young Adult Cancer Trial Enrollment: NCORP Site Perspectives.青少年和青年癌症临床试验入组的障碍和促进因素:NCORP 站点观点。
JNCI Cancer Spectr. 2021 Mar 22;5(3). doi: 10.1093/jncics/pkab027. eCollection 2021 Jun.
3
Shared barriers and facilitators to enrollment of adolescents and young adults on cancer clinical trials.青少年和青年癌症临床试验入组的共同障碍和促进因素。
Sci Rep. 2022 Mar 9;12(1):3875. doi: 10.1038/s41598-022-07703-5.
4
The Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network: A New Model for Addressing Site-Level Factors Impacting Clinical Trial Enrollment.儿童肿瘤学组青少年及成年责任研究员网络:解决影响临床试验入组的现场因素的新模式。
J Adolesc Young Adult Oncol. 2020 Aug;9(4):522-527. doi: 10.1089/jayao.2019.0139. Epub 2020 Feb 20.
5
Low Enrollment of Adolescents and Young Adults Onto Cancer Trials: Insights From the Community Clinical Oncology Program.青少年和青年参加癌症试验的入组率低:来自社区临床肿瘤项目的见解。
J Oncol Pract. 2016 Apr;12(4):e388-95. doi: 10.1200/JOP.2015.009084. Epub 2016 Mar 29.
6
Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era.SWOG 癌症研究网络临床试验中青少年和年轻成年人的入组:按治疗部位和时代的对比分析。
Cancer Med. 2020 Mar;9(6):2146-2152. doi: 10.1002/cam4.2891. Epub 2020 Feb 3.
7
A qualitative study of barriers and facilitators to adolescents and young adults' participation in cancer clinical trials: Oncologist and patient perspectives.一项关于青少年和青年参与癌症临床试验的障碍与促进因素的定性研究:肿瘤学家和患者的观点。
Pediatr Blood Cancer. 2022 Apr;69(4):e29479. doi: 10.1002/pbc.29479. Epub 2021 Dec 16.
8
Understanding the Barriers to Pediatric Oncologist Engagement and Accrual to Clinical Trials in National Cancer Institute-Designated Community Oncology Research Programs.了解国家癌症研究所指定社区肿瘤学研究项目中儿科肿瘤学家参与和入组临床试验的障碍。
JCO Oncol Pract. 2020 Oct;16(10):e1060-e1066. doi: 10.1200/JOP.19.00707. Epub 2020 May 12.
9
Comparing Barriers and Facilitators to Adolescent and Young Adult Clinical Trial Enrollment Across High- and Low-Enrolling Community-Based Clinics.比较高和低招募社区诊所青少年和青年临床试验入组的障碍和促进因素。
Oncologist. 2022 May 6;27(5):363-370. doi: 10.1093/oncolo/oyac030.
10
A prospective comparison of cancer clinical trial availability and enrollment among adolescents/young adults treated at an adult cancer hospital or affiliated children's hospital.在成人癌症医院或附属儿童医院接受治疗的青少年/青年癌症患者中,癌症临床试验的可及性和入组情况的前瞻性比较。
Cancer. 2018 Oct 15;124(20):4064-4071. doi: 10.1002/cncr.31727. Epub 2018 Oct 6.

引用本文的文献

1
Sharing is caring: a network collaborative approach to identify and address barriers in accessing clinical trials in adolescents and young adults with leukemia and lymphoma.分享即关怀:一种网络协作方法,用于识别和解决青少年及青年白血病和淋巴瘤患者参与临床试验的障碍。
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):27-33. doi: 10.1182/hematology.2024000526.
2
Champions to enhance implementation of clinical and community-based interventions in cancer: a scoping review.促进癌症临床和社区干预措施实施的倡导者:一项范围综述
Implement Sci Commun. 2024 Oct 22;5(1):119. doi: 10.1186/s43058-024-00662-0.
3
Overcoming barriers to drug development and enrollment in clinical trials for adolescents and young adults with lymphoma.克服淋巴瘤青少年和青年药物开发及临床试验入组的障碍。
EJHaem. 2023 Sep 7;4(4):921-926. doi: 10.1002/jha2.787. eCollection 2023 Nov.
4
Access to Care for Adolescents and Young Adults With Cancer in the United States: State of the Literature.美国青少年和青年癌症患者的护理途径:文献综述。
J Clin Oncol. 2024 Feb 20;42(6):642-652. doi: 10.1200/JCO.23.01027. Epub 2023 Nov 8.
5
NCI intramural program approach to rare tumors: Natural history study of rare solid tumors in children and adults: A longitudinal, comprehensive data and biospecimen collection protocol.美国国立癌症研究所内部项目针对罕见肿瘤的方法:儿童和成人罕见实体瘤的自然史研究:一项纵向、全面的数据和生物样本收集方案。
Pediatr Blood Cancer. 2023 Jun 21:e30495. doi: 10.1002/pbc.30495.
6
Rationale and design of Children's Oncology Group (COG) study ACCL20N1CD: financial distress during treatment of acute lymphoblastic leukemia in the United States.儿童肿瘤学组(COG)研究 ACCL20N1CD 的理由和设计:美国急性淋巴细胞白血病治疗期间的经济困境。
BMC Health Serv Res. 2022 Jun 28;22(1):832. doi: 10.1186/s12913-022-08201-0.
7
Challenges of Systemic Therapy Investigations for Bone Sarcomas.骨肉瘤系统治疗研究的挑战。
Int J Mol Sci. 2022 Mar 24;23(7):3540. doi: 10.3390/ijms23073540.

本文引用的文献

1
Understanding the Barriers to Pediatric Oncologist Engagement and Accrual to Clinical Trials in National Cancer Institute-Designated Community Oncology Research Programs.了解国家癌症研究所指定社区肿瘤学研究项目中儿科肿瘤学家参与和入组临床试验的障碍。
JCO Oncol Pract. 2020 Oct;16(10):e1060-e1066. doi: 10.1200/JOP.19.00707. Epub 2020 May 12.
2
A Retrospective Analysis of Clinical Trial Accrual of Patients Presented in a Multidisciplinary Tumor Board at a Tertiary Health Care Center and Associated Barriers.多学科肿瘤委员会就诊患者临床试验入组的回顾性分析及相关障碍。
Oncol Res Treat. 2020;43(5):196-203. doi: 10.1159/000506840. Epub 2020 Mar 27.
3
The Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network: A New Model for Addressing Site-Level Factors Impacting Clinical Trial Enrollment.儿童肿瘤学组青少年及成年责任研究员网络:解决影响临床试验入组的现场因素的新模式。
J Adolesc Young Adult Oncol. 2020 Aug;9(4):522-527. doi: 10.1089/jayao.2019.0139. Epub 2020 Feb 20.
4
Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era.SWOG 癌症研究网络临床试验中青少年和年轻成年人的入组:按治疗部位和时代的对比分析。
Cancer Med. 2020 Mar;9(6):2146-2152. doi: 10.1002/cam4.2891. Epub 2020 Feb 3.
5
The Clinical Trials Gap for Adolescents and Young Adults with Cancer: Recent Progress and Conceptual Framework for Continued Research.青少年和青年癌症患者的临床试验差距:近期进展与持续研究的概念框架
Curr Pediatr Rep. 2015 Jun;3(2):137-145. doi: 10.1007/s40124-015-0075-y. Epub 2015 Feb 18.
6
A Reappraisal of Sex-Specific Cancer Survival Trends Among Adolescents and Young Adults in the United States.美国青少年和年轻成年人中特定性别癌症生存趋势的再评估。
J Natl Cancer Inst. 2019 May 1;111(5):509-518. doi: 10.1093/jnci/djy140.
7
Understanding care and outcomes in adolescents and young adult with Cancer: A review of the AYA HOPE study.了解青少年和年轻成人癌症患者的护理和结局:AYA HOPE 研究综述。
Pediatr Blood Cancer. 2019 Jan;66(1):e27486. doi: 10.1002/pbc.27486. Epub 2018 Oct 7.
8
A prospective comparison of cancer clinical trial availability and enrollment among adolescents/young adults treated at an adult cancer hospital or affiliated children's hospital.在成人癌症医院或附属儿童医院接受治疗的青少年/青年癌症患者中,癌症临床试验的可及性和入组情况的前瞻性比较。
Cancer. 2018 Oct 15;124(20):4064-4071. doi: 10.1002/cncr.31727. Epub 2018 Oct 6.
9
Is the cancer survival improvement in European and American adolescent and young adults still lagging behind that in children?欧美青少年和年轻成年人的癌症存活率改善是否仍落后于儿童?
Pediatr Blood Cancer. 2019 Jan;66(1):e27407. doi: 10.1002/pbc.27407. Epub 2018 Aug 19.
10
Sink or Collaborate: How the Immersive Model Has Helped Address Typical Adolescent and Young Adult Barriers at a Single Institution and Kept the Adolescent and Young Adult Program Afloat.下沉还是合作:沉浸式模式如何在单一机构中帮助克服典型的青少年和青年障碍并维持青少年和青年项目的运营。
J Adolesc Young Adult Oncol. 2017 Dec;6(4):503-511. doi: 10.1089/jayao.2017.0051. Epub 2017 Aug 4.